Work

Microbiome modification and improvement of signs and symptoms of COVID-19: Ileocolonic-release nicotinamide in a prospective, double-blind, randomized, placebo-controlled trial

Year: 2023

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Zeitschrift für Gastroenterologie

DOI: 10.1055/s-0043-1771747

Authors: S. Schreiber, G. H. Waetzig, C. Geisler, K. Schlicht, S. Franzenburg, V. A. López-Agudelo, R. di Giuseppe, D. Pape, T. Bahmer, M. Krawczak, E. Kokott, O. Harzer, J. Kramer, T. von Schrenck, F. Sommer, H. U. Zacharias, J. Heyckendorf, K. Aden, R. Hollweck, M. Laudes, P. Rosenstiel

Institutions: Christian-Albrechts-Universität zu Kiel, University Hospital Schleswig-Holstein, Conaris, Kompetenznetz Darmerkrankungen

Language: English

Topic: Gut microbiota and health

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387952249

FWCI:

Cites:

Cited by:

Related to: 10